Evolution and selection of resistant bacteria in the presence of subinhibitory concentrations of micropollutants

微污染物亚抑制浓度下耐药细菌的进化和选择

基本信息

项目摘要

The use of wastewater for irrigation of agricultural land optimizes the efficient use of scarce water resources and the production of food under conditions of climate change. Wastewater is increasingly treated prior to its use in agriculture in order to minimize health risks, with the Mezquital Valley, Mexico, representing an important model case. The central hypothesis of the research unit FOR 5095 is that hitherto unforeseen risks arise from the implementation of wastewater treatment in long-established wastewater irrigation systems, due to i) the release of pollutants that have formerly been accumulated in soils, leading to ii) concentrations that (co-)select for antimicrobial resistance with iii) release and concentrations of antibiotics as well as selection of antibiotic resistance depending on soil type. SP 3 will contribute to testing these hypotheses by characterizing the selection pressure exerted by single antibiotics (ciprofloxacin, several MLSB antibiotics, sulfamethoxazole, trimethoprim) and disinfectants (quaternary alkylammonium compounds) as well as by their combinations in competition experiments employing strain pairs with different susceptibilities. These completion experiments will be conducted in nutrient broth solutions as well as in filtered aqueous extracts of Mexican soils (Leptosols, Phaeozems and Vertisols), in order to assess the influence of suspended colloids and solutes on the selection effects of antibiotics and biocides (collaboration with SP 1). We will use existing Acinetobacter baylyi strain pairs as well as other strain pairs (Escherichia coli, Enterococcus faecium) harboring plasmids that are isolated from Mexican soil and wastewater by SP 4 and SP 5 for the competition experiments. Employing these strain pairs, the minimum antibiotic/biocide concentrations that give selection advantages to the resistant strains will be determined and integrated into the mathematical model of the fate and effects of antibiotics and disinfectants developed by SP 7. Transcriptome experiments will give information about the stress responses of the bacteria. Screening for resistant mutants and their subsequent sequencing will show whether the presence of antibiotics in the extracts leads to selection of bacteria harboring mutations that confer resistance. The antibiograms of facultative pathogenic bacteria, that are isolated during the joint experiments from Mexican soil and wastewater by SP 4, SP 5, and SP 6, will show whether bacteria with clinically relevant multi-resistance phenotypes or plasmids that confer resistance to relevant antibiotics like beta-lactams (e.g., carbapenems) or antibiotics of last resort (e.g., colistin), are enriched in soils with a higher availability of free antibiotics or are even present on fresh produce grown on these soils. In this way, SP 3 contributes to a mechanistic understanding of interactions between pollutants, antibiotic resistance and pathogens in changing wastewater irrigation systems.
在气候变化的条件下,利用废水灌溉农地,最大限度地有效利用稀缺的水资源和粮食生产。越来越多的废水在用于农业之前进行处理,以最大限度地减少健康风险,墨西哥的梅兹奎特山谷就是一个重要的示范案例。研究单位对5095的中心假设是,在建立已久的污水灌溉系统中实施废水处理会产生迄今无法预见的风险,原因是:1)以前在土壤中积累的污染物的释放,导致2)与抗菌剂耐药性共同选择的浓度;3)抗生素的释放和浓度,以及根据土壤类型选择抗生素耐药性。SP 3将通过表征单一抗生素(环丙沙星、几种MLSB抗生素、磺胺甲恶唑、甲氧嘧啶)和消毒剂(季铵盐化合物)以及它们的组合在使用不同敏感性的菌株对的竞争实验中施加的选择压力,有助于检验这些假说。这些完井实验将在营养肉汤溶液以及墨西哥土壤的过滤水萃取物(Leptosol、Phaeozems和Vertisols)中进行,以评估悬浮胶体和溶质对抗生素和杀生剂选择效果的影响(与SP 1合作)。我们将使用现有的贝利不动杆菌菌株对以及其他含有由SP 4和SP 5从墨西哥土壤和废水中分离出的质粒的菌株对(大肠杆菌、粪肠球菌)进行竞争实验。利用这些菌株对,将确定使耐药菌株具有选择优势的最低抗生素/杀生剂浓度,并将其整合到SP 7开发的抗生素和消毒剂命运和影响的数学模型中。转录组实验将提供有关细菌应激反应的信息。对耐药突变的筛选和随后的测序将表明,提取物中是否存在抗生素,是否会导致选择含有突变的细菌。在SP4、SP5和SP6的联合实验中从墨西哥土壤和废水中分离出的兼性致病菌的抗生素图谱将显示,具有临床相关多重耐药表型或对相关抗生素(如β-内酰胺类(例如碳青霉烯类)或最后手段抗生素(如粘菌素))产生抗药性的质粒的细菌是否在游离抗生素可获得性较高的土壤中丰富,或者甚至在这些土壤上种植的新鲜农产品中存在。通过这种方式,SP3有助于在不断变化的污水灌溉系统中从机理上理解污染物、抗生素耐药性和病原体之间的相互作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Professorin Dr. Gabriele Bierbaum其他文献

Professorin Dr. Gabriele Bierbaum的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Professorin Dr. Gabriele Bierbaum', 18)}}的其他基金

The impact of bacterial activity on decay and fossilization of arthropods: An experimental approach
细菌活动对节肢动物腐烂和石化的影响:一种实验方法
  • 批准号:
    396704301
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
    Research Units
Analysis of cell wall architecture and metabolism of a vancomycin resistant Staphylococcus aureus strain
万古霉素耐药金黄色葡萄球菌菌株细胞壁结构和代谢分析
  • 批准号:
    279112404
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
    Research Grants
The mechanisms of evolution of antibiotic resistance in Staphylococcus aureus
金黄色葡萄球菌抗生素耐药性进化机制
  • 批准号:
    195232658
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
    Research Grants
Novel ribosomally synthesized peptide antibiotics from microbial genomes
来自微生物基因组的新型核糖体合成肽抗生素
  • 批准号:
    77063807
  • 财政年份:
    2008
  • 资助金额:
    --
  • 项目类别:
    Research Units
Resistenzmechanismen gegen Antibiotika mit der Zielstruktur Lipid II
具有目标结构Lipid II的抗生素的耐药机制
  • 批准号:
    5452589
  • 财政年份:
    2005
  • 资助金额:
    --
  • 项目类别:
    Research Grants
Charakterisierung des Zellwandbiosynthesekomplexes und der Vancomycinresistenz in Staphylokokken
葡萄球菌细胞壁生物合成复合物的表征和万古霉素耐药性
  • 批准号:
    5192310
  • 财政年份:
    1999
  • 资助金额:
    --
  • 项目类别:
    Research Grants
Destruction, decay, and preservation: Early fossilization of leaf compressions
破坏、腐烂和保存:叶压缩物的早期石化
  • 批准号:
    465275616
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
    Research Units
The role of microbes and biofilms in leaf fossilization
微生物和生物膜在叶子石化中的作用
  • 批准号:
    465275390
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
    Research Units

相似国自然基金

Intelligent Patent Analysis for Optimized Technology Stack Selection:Blockchain BusinessRegistry Case Demonstration
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    万元
  • 项目类别:
    外国学者研究基金项目
基于microRNA前体性质的microRNA演化研究
  • 批准号:
    31100951
  • 批准年份:
    2011
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
最优证券设计及完善中国资本市场的路径选择
  • 批准号:
    70873012
  • 批准年份:
    2008
  • 资助金额:
    27.0 万元
  • 项目类别:
    面上项目
收缩估计作为模型选择方法的有效性研究
  • 批准号:
    10771006
  • 批准年份:
    2007
  • 资助金额:
    21.0 万元
  • 项目类别:
    面上项目
连锁群选育法(Linkage Group Selection)在柔嫩艾美耳球虫表型相关基因研究中应用
  • 批准号:
    30700601
  • 批准年份:
    2007
  • 资助金额:
    17.0 万元
  • 项目类别:
    青年科学基金项目
控制厚皮甜瓜花性型基因“A“的精细构图及标记辅助育种
  • 批准号:
    30471113
  • 批准年份:
    2004
  • 资助金额:
    21.0 万元
  • 项目类别:
    面上项目

相似海外基金

Synthesizability-constrained expansion and multi-objective evolution of antitubercular compounds
抗结核化合物的可合成性约束扩展和多目标进化
  • 批准号:
    10430402
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Defining the resistome in P. falciparum: evolution and mechanism
恶性疟原虫抗性组的定义:进化和机制
  • 批准号:
    10608899
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Synthesizability-constrained expansion and multi-objective evolution of antitubercular compounds
抗结核化合物的可合成性约束扩展和多目标进化
  • 批准号:
    10594577
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Cancer Evolution and Combinatorial Cancer Therapies: Concepts and Challenges
癌症进化和组合癌症疗法:概念和挑战
  • 批准号:
    9911129
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Dissecting the evolution of targeted therapy resistance in BRAFV600E-mutant cancer
剖析 BRAFV600E 突变癌症靶向治疗耐药性的演变
  • 批准号:
    10218100
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Dissecting the evolution of targeted therapy resistance in BRAFV600E-mutant cancer
剖析 BRAFV600E 突变癌症靶向治疗耐药性的演变
  • 批准号:
    9975123
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Decoding the clinical impact of the recent evolution of metronidazole resistance on Clostridium difficile infection.
解读近期甲硝唑耐药性演变对艰难梭菌感染的临床影响。
  • 批准号:
    10660607
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
THE EVOLUTION OF PGD ADDICTION IN HUMAN PANCREATIC CANCER
人类胰腺癌 PGD 成瘾的演变
  • 批准号:
    10543775
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
THE EVOLUTION OF PGD ADDICTION IN HUMAN PANCREATIC CANCER
人类胰腺癌 PGD 成瘾的演变
  • 批准号:
    10328829
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
THE EVOLUTION OF PGD ADDICTION IN HUMAN PANCREATIC CANCER
人类胰腺癌 PGD 成瘾的演变
  • 批准号:
    10307627
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了